Billy Evans’ ‘Theranos 2.0’ startup has patents, investors, and a missing CTO—but no product

The Quick Take
As You Can See Everything turns Billy Evans into the year’s most unlikely documentary villain, his Austin startup Haemanthus faces a simple question: What has it built?
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Fortune.



